Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Gjumrakch Aliev


Gjumrakch Aliev

GALLY International Biomedical Research Consulting LLC., USA

Biography

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment  with the University of Atlanta,  Atlanta, Georgia, USA as a Professor of Cardiovascular,  Neuropathology,  Gerontology,  Health Science and Healthcare Administration, and Leading Scientist in the Institute of Physiologically Active Compounds, Russian Academy of Sciences.  He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished  his PhD in Cardiovascular  Diseases from the prestigious   Russian Academy of the Medical Sciences, Moscow, Russia  in 1988 with cum laude. He received postdoctoral training  with  Professor  G.  Burnstock  in  the  University  College  of  the  London.  He  authored  and coauthored           more  than  500  publications   in  the  fields  of  neurodegenerative diseases  research (Alzheimer    disease),   as well   as   cardio-   and   cerebrovascular    disease,   cancer,   and   electron microscopy.   He is an outstanding  teacher,  scholar,  and a renowned  scientist  in the area of cellular  molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies and drug development  including Alzheimer disease (AD).  He is nationally  and internationally  reputed in his area.               Dr. Aliev’s accomplishments  in the area of biochemistry  and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration  related pathologies.  He is world-renowned expert in electron microscopy.  His work has been published in numerous  prestigious  journals  such as Nature  Clinical  Cardiology,  J. Neuroscience,  Circulation  Research,  New England journal of Medicine, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, International  J. Biochemistry  and Cell Biology,  Scientific Reports,  and many others which reflect his leading role in his research areas. He is currently the Editor in Chiefs for “Central Nervous System Agents in Medicinal Chemistry”, “Applied Cell Biology”, “World Journal of Neuroscience”,  “Open Journal of Psychiatry” and “Journal of Aging Science”, Cardiovascular  & Hematological Agents in Medicinal Chemistry as well as which by itself shows the voluminous and outstanding work he has accomplished  in the area of cellular and molecular biology as well as aged associated clinical sciences. He is one of most cited authors in his fields with high impact factors

Abstract

Abstract : Mitochondrial Lesions as an Earlier hallmark for Liver and Brain Neuronal Damage During the Chronic Ethanol Self Administration in Cynomolgus Monkeys: New Challenge for Treatment Strategy